266 related articles for article (PubMed ID: 11318786)
1. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
Miraki-Moud F; Jenkins PJ; Fairclough PD; Jordan S; Bustin SA; Jones AM; Lowe DG; Monson JP; Grossman AB; Besser GM; Camacho-Hübner C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):499-508. PubMed ID: 11318786
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
Renehan AG; Toogood AA; Ryder WD; Jones J; Potten CS; O'Dwyer ST; Shalet SM
Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
[TBL] [Abstract][Full Text] [Related]
3. High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization.
Parkinson C; Flyvbjerg A; Trainer PJ
Growth Horm IGF Res; 2004 Feb; 14(1):59-65. PubMed ID: 14700556
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
5. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
[TBL] [Abstract][Full Text] [Related]
7. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
Chen HS; Lin HD
J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
Mohnike KL; Kluba U; Mittler U; Aumann V; Vorwerk P; Blum WF
Eur J Pediatr; 1996 Feb; 155(2):81-6. PubMed ID: 8775218
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
Tennant MK; Thrasher JB; Twomey PA; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Jan; 81(1):411-20. PubMed ID: 8550786
[TBL] [Abstract][Full Text] [Related]
12. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
[TBL] [Abstract][Full Text] [Related]
15. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma.
Ranke MB; Maier KP; Schweizer R; Stadler B; Schleicher S; Elmlinger MW; Flehmig B
Horm Res; 2003; 60(4):174-80. PubMed ID: 14530605
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
Grinspoon S; Clemmons D; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
19. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Cunha HM; Elias LL; Camacho-Hübner C; Moreira AC; Martinelli CE
Clin Endocrinol (Oxf); 2004 Jul; 61(1):94-101. PubMed ID: 15212650
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
